John C. Morris

2.7k total citations
43 papers, 2.1k citations indexed

About

John C. Morris is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, John C. Morris has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Genetics. Recurrent topics in John C. Morris's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (8 papers) and T-cell and Retrovirus Studies (7 papers). John C. Morris is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (8 papers) and T-cell and Retrovirus Studies (7 papers). John C. Morris collaborates with scholars based in United States, Germany and Slovakia. John C. Morris's co-authors include Oliver Wildner, Jay A. Berzofsky, Thomas A. Waldmann, Geoffrey I. Shapiro, Donald P. Lawrence, Bruce J. Dezube, Antoinette R. Tan, Thomas Olencki, Frank J. Hsu and John E. Janik and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

John C. Morris

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Morris United States	23	827	754	498	366	244	43	2.1k
Per Sonne Holm Germany	30	1.0k 1.3×	626 0.8×	177 0.4×	657 1.8×	170 0.7×	92	2.3k
Laura Graham United States	19	674 0.8×	651 0.9×	885 1.8×	208 0.6×	51 0.2×	39	2.0k
James M. Reuben United States	22	616 0.7×	585 0.8×	665 1.3×	103 0.3×	79 0.3×	47	2.2k
Leona Cohen‐Gould United States	27	1.5k 1.8×	269 0.4×	285 0.6×	200 0.5×	133 0.5×	43	2.9k
Réjean Lapointe Canada	30	1.0k 1.2×	1.2k 1.6×	2.1k 4.2×	243 0.7×	184 0.8×	80	4.0k
Hua Wu China	26	1.1k 1.3×	338 0.4×	293 0.6×	528 1.4×	49 0.2×	102	2.4k
Annalisa Chiocchetti Italy	33	1.0k 1.2×	343 0.5×	936 1.9×	299 0.8×	40 0.2×	101	2.9k
Chia‐Ling Wu Taiwan	25	1.8k 2.2×	882 1.2×	452 0.9×	295 0.8×	47 0.2×	68	3.5k
Dimitre R. Simeonov United States	15	922 1.1×	328 0.4×	384 0.8×	384 1.0×	124 0.5×	20	1.8k
Kenneth D. Somers United States	26	944 1.1×	466 0.6×	227 0.5×	242 0.7×	632 2.6×	70	2.7k

Countries citing papers authored by John C. Morris

Since Specialization

Citations

This map shows the geographic impact of John C. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Morris more than expected).

Fields of papers citing papers by John C. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Morris. The network helps show where John C. Morris may publish in the future.

Co-authorship network of co-authors of John C. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Morris. A scholar is included among the top collaborators of John C. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Morris. John C. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aschenbrenner, Andrew J., Suzanne E. Schindler, Shorena Janelidze, et al.. (2024). Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease. The Journal of Prevention of Alzheimer s Disease. 11(6). 1696–1702. 1 indexed citations

Gulati, Shuchi, Sarah Palackdharry, John C. Morris, et al.. (2019). Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer. Cancer. 126(2). 354–362. 37 indexed citations

Wise‐Draper, Trisha M., Sarah Palackdharry, Nooshin Hashemi Sadraei, et al.. (2017). Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma. Translational Oncology. 11(1). 168–174. 10 indexed citations

Sharma, Kamal, John E. Janik, Deirdre O’Mahony, et al.. (2016). Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma. Clinical Cancer Research. 23(1). 35–42. 36 indexed citations

Morris, John C., Antoinette R. Tan, Thomas Olencki, et al.. (2014). Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma. PLoS ONE. 9(3). e90353–e90353. 352 indexed citations

Starnes, Sandra L., Peterson Pathrose, Jiang Wang, et al.. (2012). Clinical and Molecular Predictors of Recurrence in Stage I Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 93(5). 1606–1612. 9 indexed citations

Stewart, Donn M., Roshan Ramanathan, Siddhartha Mahanty, et al.. (2011). Disseminated <i>Strongyloides stercoralis</i> Infection in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma. Acta Haematologica. 126(2). 63–67. 27 indexed citations

Martiniova, Lucia, Shiromi M. Perera, Frederieke M. Brouwers, et al.. (2010). Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine, and [3H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors. Endocrine Related Cancer. 18(1). 143–157. 33 indexed citations

Martiniova, Lucia, Edwin W. Lai, Abdel Elkahloun, et al.. (2009). Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature. Clinical & Experimental Metastasis. 26(3). 239–250. 62 indexed citations

10.

Kelly, Ronan J. & John C. Morris. (2009). Transforming growth factor-beta: A target for cancer therapy. Journal of Immunotoxicology. 7(1). 15–26. 33 indexed citations

11.

Steel, Jason C., Brian J. Morrison, Poonam Mannan, et al.. (2007). Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus. Virology. 369(1). 131–142. 23 indexed citations

12.

Steel, Jason C., Heather Cavanagh, Mark A. Burton, et al.. (2007). Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB/DOPE. European Journal of Pharmaceutical Sciences. 30(5). 398–405. 15 indexed citations

13.

Burke, John D. & John C. Morris. (2006). Retroviral Vectors Encoding a Reverse Transcription-activated Transgene Efficiently Limit Expression of the Gene to Target Cells. Molecular Therapy. 15(3). 552–559. 2 indexed citations

14.

Waes, Carter Van, Angela A. Chang, Peter F. Lebowitz, et al.. (2005). Inhibition of nuclear factor-κB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. International Journal of Radiation Oncology*Biology*Physics. 63(5). 1400–1412. 93 indexed citations

15.

Druzgal, Colleen, Zhong Chen, Ning T. Yeh, et al.. (2005). A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head & Neck. 27(9). 771–784. 78 indexed citations

16.

Morris, John C. & Oliver Wildner. (2000). Therapy of Head and Neck Squamous Cell Carcinoma with an Oncolytic Adenovirus Expressing HSV-tk. Molecular Therapy. 1(1). 56–62. 64 indexed citations

17.

Wildner, Oliver, John C. Morris, Nicholas N. Vahanian, et al.. (1999). Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer. Gene Therapy. 6(1). 57–62. 141 indexed citations

18.

Morrow‐Howell, Nancy, Dorothy Farrar Edwards, Carolyn Baum, et al.. (1999). Home-Based Multidisciplinary Diagnosis and Treatment of Inner-City Elders With Dementia. The Gerontologist. 39(4). 483–488. 19 indexed citations

19.

Rubin, Eugene H., Martha Storandt, J. Philip Miller, et al.. (1998). A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy Elders. Archives of Neurology. 55(3). 395–395. 250 indexed citations

20.

Morris, John C.. (1988). Early Alzheimer's Disease. Archives of Neurology. 45(3). 345–345. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact